Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
131.50B
Market cap131.50B
Price-Earnings ratio
25.06
Price-Earnings ratio25.06
Dividend yield
2.81%
Dividend yield2.81%
Average volume
8.51M
Average volume8.51M
High today
—
High today—
Low today
—
Low today—
Open price
$102.74
Open price$102.74
Volume
0.00
Volume0.00
52 Week high
$106.33
52 Week high$106.33
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

The current Medtronic(MDT) stock price is $102.75, with a market capitalization of 131.5B. The stock trades at a price-to-earnings (P/E) ratio of 25.06 and offers a dividend yield of 2.81%.

Medtronic(MDT) stock opened on 2026-11-10 at $102.74. The price climbed to — and dipped to —.

The Medtronic(MDT)'s current trading volume is 0, compared to an average daily volume of 8.51M.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $73.31.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $73.31.

MDT News

Simply Wall St 7h
How Positive Renal Denervation Data Will Impact Medtronic Stock

Medtronic reported past six month results from its SPYRAL AFFIRM post approval study, showing statistically significant blood pressure reductions with the Sympl...

How Positive Renal Denervation Data Will Impact Medtronic Stock
Simply Wall St 4d
What Is Medtronic Asking Of Hypertension Care With Its FDA Label Update?

Medtronic (NYSE:MDT) reported positive real world outcomes from its Symplicity Spyral renal denervation system in hypertension patients in 2026. The new data s...

What Is Medtronic Asking Of Hypertension Care With Its FDA Label Update?

Analyst ratings

61%

of 31 ratings
Buy
61.3%
Hold
38.7%
Sell
0%

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.